Incyte (INCY) Other Working Capital Changes (2010 - 2026)

Incyte's (INCY) quarterly Other Working Capital Changes came in at $14.0 million in Q2 2026, down 83.75% YoY from $86.4 million in Q2 2025, and up 252.75% on a QoQ basis from -$9.2 million in Q1 2026.

Incyte (INCY) Other Working Capital Changes (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Other Working Capital Changes data on file, last reported at $14.0 million in Q2 2026.

  • Quarterly Other Working Capital Changes fell 83.75% year-over-year to $14.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.6 million (down 87.14% YoY) and the FY2025 annual result came in at $156.2 million, up 1607.35% from the prior year.
  • Other Working Capital Changes climbed to $14.0 million in Q2 2026, from -$9.2 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $86.4 million in Q2 2025 to a low of -$65.7 million in Q4 2024.
  • A 5-year average of $12.4 million and a median of $14.0 million in 2022 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2023 — Other Working Capital Changes sank 241.42% — and 2025, when it jumped 3554.0%.
  • Tracing INCY's Other Working Capital Changes over 5 years: stood at -$9.3 million in 2022, then tumbled by 111.17% to -$19.6 million in 2023, then tumbled by 235.61% to -$65.7 million in 2024, then gained by 1.08% to -$65.0 million in 2025, then jumped by 121.59% to $14.0 million in 2026.
  • The last three Other Working Capital Changes figures came in at $14.0 million (Q2 2026), -$9.2 million (Q1 2026), and -$65.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 14.04 Mn
Jun 30, 2026 14.04 Mn
Jun 30, 2026 14.04 Mn
Mar 31, 2026 -9.19 Mn
Mar 31, 2026 -9.19 Mn
Mar 31, 2026 -9.19 Mn
Dec 31, 2025 -65.04 Mn
Dec 31, 2025 -65.04 Mn
Dec 31, 2025 -65.04 Mn
Sep 30, 2025 72.84 Mn
Sep 30, 2025 72.84 Mn
Sep 30, 2025 72.84 Mn
Jun 30, 2025 86.40 Mn
Jun 30, 2025 86.40 Mn
Jun 30, 2025 86.40 Mn
Mar 31, 2025 62.05 Mn
Mar 31, 2025 62.05 Mn
Mar 31, 2025 62.05 Mn
Dec 31, 2024 -65.75 Mn
Dec 31, 2024 -65.75 Mn